
Health Check: It’s sale time as Medadvisor mulls Aussie exit and Althea renounces medicinal cannabis
It's all smiles as Medadvisor and Althea enter sales agreements for non-core assets. Pic via Getty Medadvisor shares soar up to 60% after the company flags the sale of its Australian business Pot stock Althea sees better fortunes in the THC-infused …